Lee Jun Ho, Ryu Keun Won, Kim Chan Gyoo, Kim Seok-Ki, Lee Jong-Seok, Kook Myeong-Cherl, Choi Il Ju, Kim Young Woo, Chang Hee Jin, Bae Jae-Moon
Research Institute and Hospital, National Cancer Center, 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, South Korea.
Ann Surg Oncol. 2006 Sep;13(9):1168-74. doi: 10.1245/s10434-006-9038-4. Epub 2006 Aug 20.
The results of sentinel node (SN) biopsy have been improved by the use of dye and isotope double tracers in melanoma and breast cancer. However, the usefulness of this double tracer technique has not been determined in gastric cancer. The aim of this study was to investigate the possibility of improving SN biopsy results by using double tracers in gastric cancer.
Sixty-four gastric adenocarcinoma patients preoperatively diagnosed as cT1N0, were enrolled in the study. (99m)Tc tin colloid was injected by preoperative endoscopy, and lymphoscintigraphy was performed prior to operation. After laparotomy, isosulfan blue was intraoperatively injected using an endoscope. Blue-stained or radioactive nodes were identified and defined as SNs. Gastrectomy with D2 lymphadenectomy was performed in all patients. All dissected lymph nodes were evaluated for metastasis by hematoxylin and eosin staining and immunohistochemistry.
SN detection rates using dye, isotope, or both tracers were 95.3%, 84.4%, and 96.9%, respectively, and their corresponding sensitivities were 52.9%, 52.9%, and 70.6%. In the pT1 subset, the sensitivity of the double tracer was 87.5%; and in a subset of tumors with diameter <4.5 cm, this was also 87.5%.
These findings confirm that SN biopsy results are improved by using double tracers in gastric cancer and suggest that SN biopsy is suitable in cases of small-sized early gastric cancer.
在黑色素瘤和乳腺癌中,通过使用染料和同位素双示踪剂,前哨淋巴结(SN)活检的结果得到了改善。然而,这种双示踪剂技术在胃癌中的实用性尚未得到确定。本研究的目的是探讨在胃癌中使用双示踪剂改善SN活检结果的可能性。
64例术前诊断为cT1N0的胃腺癌患者纳入本研究。术前通过内镜注射(99m)Tc硫胶体,并在手术前进行淋巴闪烁显像。剖腹手术后,术中使用内镜注射异硫蓝。识别出蓝色染色或有放射性的淋巴结并将其定义为前哨淋巴结。所有患者均行D2淋巴结清扫的胃切除术。所有切除的淋巴结通过苏木精和伊红染色及免疫组织化学评估有无转移。
使用染料、同位素或两种示踪剂的前哨淋巴结检测率分别为95.3%、84.4%和96.9%,其相应的敏感性分别为52.9%、52.9%和70.6%。在pT1亚组中,双示踪剂的敏感性为87.5%;在肿瘤直径<4.5 cm的亚组中,也是87.5%。
这些发现证实,在胃癌中使用双示踪剂可改善前哨淋巴结活检结果,并表明前哨淋巴结活检适用于小尺寸早期胃癌病例。